Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · International Stock · American Funds (Capital Group)

American Funds International Vantage Fund Class 529-F-3 (CIVHX)

Ticker CIVHX · Since 2020-10-30 · · Holdings as of Jul 31, 2026

Expense ratio
0.59%$59/yr per $10k
1-yr return
+1.3%as of Dec 2024
Net assets
$2.7Ball share classes
Holdings
131

Bottom line

Is CIVHX a good fund? The bottom line

CIVHX is the Class 529-F-3 share class of American Funds International Vantage Fund, a managed international stock mutual fund from American Funds (Capital Group).

It charges 0.59% — about $59 a year on every $10,000 invested, cheaper than 78% of international stock funds we track.

It returned +1.3% over one year (as of Dec 31, 2024, per its prospectus).

With $2.7 billion in net assets and 131 holdings, its largest position is Asml Holding Nv (4.6%) and the top 10 make up 24.6% of the portfolio.

What stands out

  • Low cost: cheaper than 78% of international stock peers
  • No front-end sales load

Updated Nov 19, 2026

What CIVHX invests in

The funds investment objective is to provide prudent growth of capital and conservation of principal.

The fund invests primarily in common stocks outside of the United States that the investment adviser believes have the potential for growth, many of which have the potential to pay dividends. Under normal market conditions, the fund will invest at least 80% of its net assets in equity-type securities and at least 80% of its net assets outside the United States. The fund may invest up to 10% of its net assets in the securities of issuers based in emerging markets. In pursuing the funds objective, the funds investment adviser focuses primarily on companies with attributes that are associated with long-term growth and resilience to market declines, such as strong management, participation in a growing market, strong balance sheets, payment of dividends and the potential for above average growth in earnings, revenues, book value, cash flow and/or return on assets. The investment adviser…

From the fund's prospectus (filed Dec 31, 2025).

CIVHX performance

Average annual total returns
1 yr5 yr10 yr
CIVHX+1.3%——
International Stock median+25.5%+6.4%+7.6%

Source: Fund prospectus, as of Dec 31, 2024

Full CIVHX performance history →

What CIVHX costs

On a $10,000 investment, CIVHX's 0.59% expense ratio costs about $59 a year. The prospectus estimates $749 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.

See the full CIVHX fee table →

CIVHX top 10 holdings

#Holding% of fund
1Asml Holding Nv ASML4.63%
2Capital Group Central Cash Fund3.21%
3Astrazeneca Plc AZN2.38%
4Rolls-royce Holdings Plc RR/2.28%
5Taiwan Semiconductor Manufacturing Co Ltd TSM2.25%
6Totalenergies Se TTE2.11%
7Skandinaviska Enskilda Banken Ab SEBA2.02%
8Engie Sa ENGI1.99%
9Unicredit Spa UCG1.91%
10Airbus Se AIR1.77%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 24.6% of the fund. See all top 25 holdings and asset mix →

Alternatives to CIVHX

More funds like CIVHX →

CIVHX FAQ

What is the expense ratio of CIVHX?
CIVHX's expense ratio is 0.59%, which works out to about $59 a year for every $10,000 invested. The prospectus estimates total costs of $749 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is CIVHX a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 78% of international stock peers; no front-end sales load. This is general information, not personalized advice.
What does CIVHX hold?
CIVHX's largest holdings are Asml Holding Nv (4.6%), Capital Group Central Cash Fund (3.2%), Astrazeneca Plc (2.4%), Rolls-royce Holdings Plc (2.3%), Taiwan Semiconductor Manufacturing Co Ltd (2.2%). It holds 131 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
Does CIVHX have a sales load?
No. CIVHX has no front-end sales charge.
Who manages CIVHX?
CIVHX is offered by American Funds (Capital Group) through American Funds International Vantage Fund.